Transamerica Financial Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1
| Closed | -$1K | – | 701 |
|
|
2023
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 621 |
|
|
2023
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 642 |
|
|
2023
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 614 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$1K | – | 717 |
|
|
2022
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 686 |
|
|
2022
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 641 |
|
|
2022
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 649 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$1K | – | 513 |
|
|
2020
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 501 |
|
|
2019
Q3 | – | Sell |
-1
| Closed | -$1K | – | 549 |
|
|
2019
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 546 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$1K | – | 483 |
|
|
2018
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 496 |
|
|
2018
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 493 |
|
|
2018
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 483 |
|
|
2018
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 439 |
|
|
2017
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 416 |
|
|
2017
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 406 |
|
|
2017
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 383 |
|
|
2017
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 375 |
|
|
2016
Q4 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 410 |
|
|
2015
Q3 | – | Sell |
-2
| Closed | -$1K | – | 926 |
|
|
2015
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 868 |
|
|
2015
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 867 |
|
|
2014
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 708 |
|
|
2014
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 663 |
|
|
2014
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 671 |
|
|
2014
Q1 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 632 |
|